URO-1

URO-1

Early stage medical products developer for urology procedures.

HQ location
Winston-Salem, United States
Launch date
Employees
Enterprise value
$32—48m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
*

$8.0m

Series A
Total Funding000k
Notes (0)
More about URO-1
Made with AI
Edit

URO 1 is an emerging medical device company specializing in the development of disposable products for office procedures in the fields of urogynecology and urology. The company's inaugural product, the Bladder Injection System, has recently received clearance from the US FDA. This system is specifically designed to minimize complications following onabotulinumtoxinA treatment for overactive bladder (OAB) in women. Key features include a unique memory cannula platform and a no-look self-metering syringe, which aim to enhance the precision and safety of the procedure. URO 1 primarily serves healthcare providers specializing in urogynecology and urology, operating within the medical device market. The company's business model revolves around the development, patenting, and commercialization of innovative medical devices. Revenue is generated through the sale of these disposable products to medical professionals and healthcare institutions. Additional products are currently in late-stage development, indicating a pipeline of future offerings that could further expand the company's market presence.

Keywords: medical devices, urogynecology, urology, disposable products, FDA-cleared, bladder injection, overactive bladder, memory cannula, self-metering syringe, healthcare providers.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo